18F-rhPSMA-7 positron emission tomography (PET) for the detection of biochemical recurrence of prostate cancer following curative-intent radiation therapy

Conclusions: 18F-rhPSMA-7 PET/CT demonstrates high detection rates in patients with biochemical recurrence of prostate cancer after primary radiation therapy. The detection rate was broadly proportional to PSA level and appears to be similar to published data for other PSMA ligands.

Source: Journal of Nuclear Medicine - May 20, 2019 Category: Nuclear Medicine Authors: Ilhan, H., Kroenke, M., Wurzer, A., Ulbrich, L., JooAY, L., Unterrainer, M., Bartenstein, P., Kropf, S., Wester, H., Weber, W., Eiber, M. Tags: Prostate Diagnosis I Source Type: research